Report Detail
Global Small Molecule CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4356560 |
- 29 November, 2021 |
- Global |
- 115 Pages |
- QYResearch |
- Medical Industry
Summary:
Market Insights
QY Research has lately published a report titled “Global Small Molecule CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Small Molecule CDMO market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Development
API Production
Segment by Application
Pharmaceutical
Biopharmaceutical
Regional Scope
This segment of the report offers a thorough regional study of the global Small Molecule CDMO market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Frequently Asked Questions
Which application segment captured the leading share in the Small Molecule CDMO market?
How fragmented is the Small Molecule CDMO market?
Which are the key growth drivers in the Small Molecule CDMO market?
Which are the top strategies undertaken by the Small Molecule CDMO market players?
Which technological trends are likely to affect the Small Molecule CDMO market?
What is the expected Small Molecule CDMO market size by 2027?
Which companies are dominating the Small Molecule CDMO market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Small Molecule CDMO market growth?
Which are the emerging companies in the Small Molecule CDMO market?
Table of Contents
1 Market Overview of Small Molecule CDMO
- 1.1 Small Molecule CDMO Market Overview
- 1.1.1 Small Molecule CDMO Product Scope
- 1.1.2 Small Molecule CDMO Market Status and Outlook
- 1.2 Global Small Molecule CDMO Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Small Molecule CDMO Market Size by Region (2016-2027)
- 1.4 Global Small Molecule CDMO Historic Market Size by Region (2016-2021)
- 1.5 Global Small Molecule CDMO Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Small Molecule CDMO Market Size (2016-2027)
- 1.6.1 North America Small Molecule CDMO Market Size (2016-2027)
- 1.6.2 Europe Small Molecule CDMO Market Size (2016-2027)
- 1.6.3 Asia-Pacific Small Molecule CDMO Market Size (2016-2027)
- 1.6.4 Latin America Small Molecule CDMO Market Size (2016-2027)
- 1.6.5 Middle East & Africa Small Molecule CDMO Market Size (2016-2027)
2 Small Molecule CDMO Market Overview by Type
- 2.1 Global Small Molecule CDMO Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Small Molecule CDMO Historic Market Size by Type (2016-2021)
- 2.3 Global Small Molecule CDMO Forecasted Market Size by Type (2022-2027)
- 2.4 Development
- 2.5 API Production
3 Small Molecule CDMO Market Overview by Application
- 3.1 Global Small Molecule CDMO Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Small Molecule CDMO Historic Market Size by Application (2016-2021)
- 3.3 Global Small Molecule CDMO Forecasted Market Size by Application (2022-2027)
- 3.4 Pharmaceutical
- 3.5 Biopharmaceutical
4 Small Molecule CDMO Competition Analysis by Players
- 4.1 Global Small Molecule CDMO Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2020)
- 4.3 Date of Key Players Enter into Small Molecule CDMO Market
- 4.4 Global Top Players Small Molecule CDMO Headquarters and Area Served
- 4.5 Key Players Small Molecule CDMO Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Small Molecule CDMO Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Lonza
- 5.1.1 Lonza Profile
- 5.1.2 Lonza Main Business
- 5.1.3 Lonza Small Molecule CDMO Products, Services and Solutions
- 5.1.4 Lonza Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.1.5 Lonza Recent Developments
- 5.2 Catalent
- 5.2.1 Catalent Profile
- 5.2.2 Catalent Main Business
- 5.2.3 Catalent Small Molecule CDMO Products, Services and Solutions
- 5.2.4 Catalent Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.2.5 Catalent Recent Developments
- 5.3 Thermo Fisher
- 5.3.1 Thermo Fisher Profile
- 5.3.2 Thermo Fisher Main Business
- 5.3.3 Thermo Fisher Small Molecule CDMO Products, Services and Solutions
- 5.3.4 Thermo Fisher Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.3.5 Wuxi Apptec Recent Developments
- 5.4 Wuxi Apptec
- 5.4.1 Wuxi Apptec Profile
- 5.4.2 Wuxi Apptec Main Business
- 5.4.3 Wuxi Apptec Small Molecule CDMO Products, Services and Solutions
- 5.4.4 Wuxi Apptec Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.4.5 Wuxi Apptec Recent Developments
- 5.5 PharmaBlock
- 5.5.1 PharmaBlock Profile
- 5.5.2 PharmaBlock Main Business
- 5.5.3 PharmaBlock Small Molecule CDMO Products, Services and Solutions
- 5.5.4 PharmaBlock Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.5.5 PharmaBlock Recent Developments
- 5.6 Asym Chemical
- 5.6.1 Asym Chemical Profile
- 5.6.2 Asym Chemical Main Business
- 5.6.3 Asym Chemical Small Molecule CDMO Products, Services and Solutions
- 5.6.4 Asym Chemical Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.6.5 Asym Chemical Recent Developments
- 5.7 Jiuzhou Pharmaceutical
- 5.7.1 Jiuzhou Pharmaceutical Profile
- 5.7.2 Jiuzhou Pharmaceutical Main Business
- 5.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Products, Services and Solutions
- 5.7.4 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.7.5 Jiuzhou Pharmaceutical Recent Developments
- 5.8 Pharmaron Beijing
- 5.8.1 Pharmaron Beijing Profile
- 5.8.2 Pharmaron Beijing Main Business
- 5.8.3 Pharmaron Beijing Small Molecule CDMO Products, Services and Solutions
- 5.8.4 Pharmaron Beijing Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.8.5 Pharmaron Beijing Recent Developments
- 5.9 Porton Pharma
- 5.9.1 Porton Pharma Profile
- 5.9.2 Porton Pharma Main Business
- 5.9.3 Porton Pharma Small Molecule CDMO Products, Services and Solutions
- 5.9.4 Porton Pharma Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.9.5 Porton Pharma Recent Developments
- 5.10 ChemPartner
- 5.10.1 ChemPartner Profile
- 5.10.2 ChemPartner Main Business
- 5.10.3 ChemPartner Small Molecule CDMO Products, Services and Solutions
- 5.10.4 ChemPartner Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.10.5 ChemPartner Recent Developments
- 5.11 Jiangsu Sinopep
- 5.11.1 Jiangsu Sinopep Profile
- 5.11.2 Jiangsu Sinopep Main Business
- 5.11.3 Jiangsu Sinopep Small Molecule CDMO Products, Services and Solutions
- 5.11.4 Jiangsu Sinopep Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.11.5 Jiangsu Sinopep Recent Developments
- 5.12 DELPHARM
- 5.12.1 DELPHARM Profile
- 5.12.2 DELPHARM Main Business
- 5.12.3 DELPHARM Small Molecule CDMO Products, Services and Solutions
- 5.12.4 DELPHARM Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.12.5 DELPHARM Recent Developments
- 5.13 Aenova Group
- 5.13.1 Aenova Group Profile
- 5.13.2 Aenova Group Main Business
- 5.13.3 Aenova Group Small Molecule CDMO Products, Services and Solutions
- 5.13.4 Aenova Group Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.13.5 Aenova Group Recent Developments
- 5.14 Siegfried Holding AG
- 5.14.1 Siegfried Holding AG Profile
- 5.14.2 Siegfried Holding AG Main Business
- 5.14.3 Siegfried Holding AG Small Molecule CDMO Products, Services and Solutions
- 5.14.4 Siegfried Holding AG Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.14.5 Siegfried Holding AG Recent Developments
- 5.15 Recipharm AB
- 5.15.1 Recipharm AB Profile
- 5.15.2 Recipharm AB Main Business
- 5.15.3 Recipharm AB Small Molecule CDMO Products, Services and Solutions
- 5.15.4 Recipharm AB Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.15.5 Recipharm AB Recent Developments
- 5.16 FAREVA SA
- 5.16.1 FAREVA SA Profile
- 5.16.2 FAREVA IN MAIN BUSINESS
- 5.16.3 FAREVA SA Small Molecule CDMO Products, Services and Solutions
- 5.16.4 FAREVA SA Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.16.5 FAREVA SA Recent Developments
- 5.17 Almac Group
- 5.17.1 Almac Group Profile
- 5.17.2 Almac Group Main Business
- 5.17.3 Almac Group Small Molecule CDMO Products, Services and Solutions
- 5.17.4 Almac Group Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.17.5 Almac Group Recent Developments
- 5.18 Cambrex
- 5.18.1 Cambrex Profile
- 5.18.2 Cambrex Main Business
- 5.18.3 Cambrex Small Molecule CDMO Products, Services and Solutions
- 5.18.4 Cambrex Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.18.5 Cambrex Recent Developments
- 5.19 Charles River
- 5.19.1 Charles River Profile
- 5.19.2 Charles River Main Business
- 5.19.3 Charles River Small Molecule CDMO Products, Services and Solutions
- 5.19.4 Charles River Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.19.5 Charles River Recent Developments
- 5.20 CORDEN PHARMA
- 5.20.1 CORDEN PHARMA Profile
- 5.20.2 CORDEN PHARMA Main Business
- 5.20.3 CORDEN PHARMA Small Molecule CDMO Products, Services and Solutions
- 5.20.4 CORDEN PHARMA Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.20.5 CORDEN PHARMA Recent Developments
- 5.21 Jubilant Pharmova
- 5.21.1 Jubilant Pharmova Profile
- 5.21.2 Jubilant Pharmova Main Business
- 5.21.3 Jubilant Pharmova Small Molecule CDMO Products, Services and Solutions
- 5.21.4 Jubilant Pharmova Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.21.5 Jubilant Pharmova Recent Developments
- 5.22 Consort Medical
- 5.22.1 Consort Medical Profile
- 5.22.2 Consort Medical Main Business
- 5.22.3 Consort Medical Small Molecule CDMO Products, Services and Solutions
- 5.22.4 Consort Medical Small Molecule CDMO Revenue (US$ Million) & (2016-2021)
- 5.22.5 Consort Medical Recent Developments
6 North America
- 6.1 North America Small Molecule CDMO Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Small Molecule CDMO Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Small Molecule CDMO Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Small Molecule CDMO Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Small Molecule CDMO Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Small Molecule CDMO Market Dynamics
- 11.1 Small Molecule CDMO Industry Trends
- 11.2 Small Molecule CDMO Market Drivers
- 11.3 Small Molecule CDMO Market Challenges
- 11.4 Small Molecule CDMO Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Small Molecule CDMO. Industry analysis & Market Report on Small Molecule CDMO is a syndicated market report, published as Global Small Molecule CDMO Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Small Molecule CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
